4888 — Stella Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- ¥10bn
- ¥8bn
- ¥961m
Annual cashflow statement for Stella Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -656 | -764 | -776 | -761 | -138 |
| Depreciation | |||||
| Non-Cash Items | 12 | 7.85 | -1.29 | 6.58 | 61.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -160 | -359 | -85.5 | -157 | 182 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -773 | -1,081 | -828 | -877 | 140 |
| Capital Expenditures | -22.4 | -46.3 | -29.3 | -11 | -12.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.42 | -304 | -0.596 | 1.97 | 300 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -22.9 | -351 | -29.9 | -9.01 | 288 |
| Financing Cash Flow Items | -372 | 373 | 13.5 | 0.103 | -4.53 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -332 | 3,829 | 292 | 228 | 721 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,128 | 2,398 | -566 | -657 | 1,149 |